Trial Profile
CSP 546 - A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease (TEAM-AD).
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Memantine (Primary) ; Tocopherol
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Acronyms TEAM-AD
- 01 Jan 2014 Results published in the JAMA: the Journal of the American Medical Association.
- 01 Sep 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 May 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.